NEW YORK (GenomeWeb News) – Seegene said today that its PCR-based test for detecting viral diarrhea has been cleared for use in Canada by a government health regulator.
The company’s Seeplex Diarrhea-V ACE Detection test received a Medical Device License from Health Canada.
The company, based in Rockville, Md., and Seoul, Korea, said that the test has already been permitted for use in more than 30 countries recognizing the CE Mark.